< RETURN TO {R}EVOLUTION

XENO NEST

Cultivate hope. Transplant the future.

Marinid

VISUALIZATION OF A PORCULOID

Organ shortages are a global emergency. Every day, countless people wait for life-saving transplants — but the number of available organs is far too low. At the same time, medical breakthroughs are slowed down by ethical and legal limitations that prevent direct testing on humans. To address both problems, pigs are now being genetically merged with human DNA. These hybrid organisms could one day provide compatible organs — and accelerate biomedical research without putting human lives at risk.

}R{EVOLUTION PROJECT

GIR- INJECTION TYPE

XENO NEST

PRIMARY GENES

PIG

SECONDARY GENES

HUMAN

NEW SPECIES

SUS SAPIOGENUS / PORCULOID

FIELD OF USE

ORGAN DONATION / MEDICAL TESTING

HUMAN ORGAN PRODUCTION VIA POSTNATAL GENETIC TRANSFORMATION

As global demand for transplantable organs surges and ethical barriers constrain human testing, Xeno Nest introduces a novel biomedical approach: the transformation of living swine into human-compatible organ donors through targeted genetic recombination.

By injecting select strands of human DNA into mature pigs, their physiology is gradually modified to express humanized tissue structures — allowing the growth of hearts, lungs, and kidneys with high immunological compatibility. Beyond organ production, these genetically augmented pigs offer unprecedented accuracy for medical testing, providing real-time insight into human treatment effects without the limitations of in vitro or rodent models.

Rather than editing humans or breeding chimeric embryos, Xeno Nest leverages the adaptability of postnatal organisms to meet urgent medical needs — bridging ethical, logistical, and biological gaps in healthcare innovation.